So far, antibodies against thrombin, PC, plasmin, and FXa have been detected in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), allowing researchers to characterize their role in the underlying pathways that lead to disease onset [15]. Here, F10 is linked to systemic lupus erythematosus.